化疗联合RA233治疗燕麦细胞肺癌。
Chemotherapy plus RA233 in the treatment of oat cell lung cancer.
作者信息
Lipton A, Harvey H A, Walker B, Dixon R, Valdivia D, Barnes S, Gordon R, White-Hershey D, Bartholomew M J, Warzawski N
机构信息
Department of Medicine, Milton S. Hershey Medical Center, Hershey, PA 17033.
出版信息
Am J Clin Oncol. 1989 Jun;12(3):259-63. doi: 10.1097/00000421-198906000-00016.
Abstract
One hundred and one patients with oat (small) cell lung cancer have been treated with CAVE [Cytoxan, Adriamycin, Vincristine, and etoposide (VP-16)] chemotherapy +/- RA233 (a platelet-inhibiting agent). There was no difference in disease-free interval, pattern of relapse, or survival between groups.
摘要
101例燕麦（小）细胞肺癌患者接受了CAVE[环磷酰胺、阿霉素、长春新碱和依托泊苷（VP-16）]化疗±RA233（一种血小板抑制剂）治疗。两组之间在无病间期、复发模式或生存率方面没有差异。
Zotero 插件